2008-07-02 23:41:18 -
www.companiesandmarkets.com adds new report - Vertex Pharmaceuticals Inc. - SWOT Analysis
www.companiesandmarkets.com/Summary-Company-Profile/Vertex-Pharm ..
Vertex Pharmaceuticals Inc. Company Profile is the essential source for top-level company data and information. The report examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Vertex Pharmaceuticals (Vertex) is a biotechnology company engaged in discovering, developing and commercializing small molecule drugs for the treatment of major diseases like HIV infection, hepatitis C virus infection, cancer, and inflammatory and autoimmune disorders. The company primarily operates in the US. It is headquartered in Cambridge, Massachusetts and has about 945 employees. The company recorded revenues of $216.4 million during the fiscal year ended December 2006, an increase of 34.5% over 2005. The operating loss of the company was $229
million during fiscal year 2006, when compared with an operating loss of $149.8 million in 2005. The net loss was $206.9 million in fiscal year 2006, when compared with a net loss of $203.4 million in 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors business structure, strategy and prospects
- Obtain the most up to date company information available
